[1] Davies H,Bignell GR,Cox C,et al.Mutations of the BRAF gene in human cancer.Nature,2002,417;949-954. [2] Smalley KS,Herlyn M.Loitering with intent;new evidence for the role of BRAF mutations in the proliferation of melanocytic lesions.J Invest Dermatol,2004,123;xvi-xvii. [3] Hannon GJ.RNA interference.Nature,2002,418;244-251. [4] Paddison PJ,Caudy AA,Hannon GJ.Stable suppression of gene expression by RNAi in mammalian cells.Proc Natl Acad Sci U S A,2002,99;1443-1448. [5] Brummelkamp TR,Bernards R,Agami R.A system for stable expression of short interfering RNAs in mammalian cells.Science,2002,296;550-553. [6] Shi Y.Mammalian RNAi for the masses.Trends Genet,2003,19;9-12. [7] Akslen LA,Angelini S,Straume O,et al.BRAF and NRAS mutations are frequent in nodular melanoma but are not associated with tumor cell proliferation or patient survival.J Invest Dermatol,2005,125;312-317. [8] Hoeflich KP,Gray DC,Eby MT,et al.Oncogenic BRAF is required for tumor growth and maintenance in melanoma models.Cancer Res,2006,66;999-1006. [9] Sumimoto H,Miyagishi M,Miyoshi H,et al.Inhibition of growth and invasive ability of melanoma by inactivation of mutated BRAF with lentivirus-mediated RNA interference.Oncogene,2004,23;6031-6039. [10] Aoyama Y,Avruch J,Zhang XF.Norel inhibits tumor cell growth independent of Ras or the MST1/2 kinases.Oncogene,2004,23;3426-3433. [11] Hingorani SR,Jacobetz MA,Robertson GP,et al.Suppression of BRAF (V599E) in human melanoma abrogates transformation.Cancer Res,2003,63;5198-5202. |